IN2013MU02469A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU02469A IN2013MU02469A IN2469MU2013A IN2013MU02469A IN 2013MU02469 A IN2013MU02469 A IN 2013MU02469A IN 2469MU2013 A IN2469MU2013 A IN 2469MU2013A IN 2013MU02469 A IN2013MU02469 A IN 2013MU02469A
- Authority
- IN
- India
- Prior art keywords
- chitosan
- targeted
- relates
- core shell
- anticancer drugs
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 239000011258 core-shell material Substances 0.000 abstract 1
- 239000002105 nanoparticle Substances 0.000 abstract 1
- 230000001960 triggered effect Effects 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to chitosan-lipid core shell nanoparticles for targeted and triggered delivery of two or more anticancer drugs which act synergistically.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2469MU2013 IN2013MU02469A (en) | 2013-07-25 | 2013-07-25 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2469MU2013 IN2013MU02469A (en) | 2013-07-25 | 2013-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU02469A true IN2013MU02469A (en) | 2015-06-26 |
Family
ID=54395828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2469MU2013 IN2013MU02469A (en) | 2013-07-25 | 2013-07-25 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU02469A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113384530A (en) * | 2020-03-13 | 2021-09-14 | 暨南大学 | Polysaccharide core Nanocells and preparation method and application thereof |
-
2013
- 2013-07-25 IN IN2469MU2013 patent/IN2013MU02469A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113384530A (en) * | 2020-03-13 | 2021-09-14 | 暨南大学 | Polysaccharide core Nanocells and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL291932B2 (en) | Nanoparticle compositions for sustained therapy | |
| PT3458074T (en) | Compositions for the delivery of trna as nanoparticles and methods of use therewith | |
| BR112015007866A2 (en) | combination of opioids and anticancer drugs for cancer treatment. | |
| SG11201510284XA (en) | Delivery and use of the crispr-cas systems, vectors and compositions for hepatic targeting and therapy | |
| MX2015014046A (en) | Drug combinations to treat cancer. | |
| PT3031826T (en) | Pharmaceutical composition for treatment and/or prevention of cancer | |
| EP4005604B8 (en) | Delivery of drugs | |
| GB201302427D0 (en) | Nanoparticle delivery compositions | |
| MX2015011783A (en) | Methods of treatment of pediatric solid tumor. | |
| IN2013MU03918A (en) | ||
| EP2999461A4 (en) | Targeted delivery of drugs to the myometrium | |
| AU2014271207A1 (en) | Targeted delivery of drugs to the myometrium | |
| PT2827858T (en) | Administration of an antitumor agent | |
| MX2018000611A (en) | Improved nanoparticle delivery systems. | |
| IN2013MU03641A (en) | ||
| MX2016006087A (en) | Rapidly disintegrating formulations and methods of use. | |
| MX2020009966A (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine. | |
| IL257983A (en) | Enhanced delivery of drugs to the brain | |
| GB201419540D0 (en) | Delivery of drugs | |
| EP2949326A4 (en) | Combination molecularly targeted drug for tumor therapy and prevention | |
| GB201319437D0 (en) | Delivery of drugs | |
| IN2013MU02469A (en) | ||
| IL250637A0 (en) | Targeted delivery of hydrophilic drugs | |
| IN2013MU03801A (en) | ||
| GB201603522D0 (en) | Pyrazolochalcones as potential anticancer agents |